EXPR - Tine cycles
EXPR daily chart with the length of the prior bull runs tracked in days. Excluded the 2019 run as it was corrective in nature/didn't conform.
From this count, on average the last 4 prior runs going back to 2011 lasted 435.75 days. The shortest run was 378 days.
Current run is 287 days. Thus current run is predicted to end by sometime in the 4th quarter 2021. See chart.
I also looked at the average price increase for the last four runs - which was ~1101 bars. Currently equates to a price of $11.67.
In terms of other indicators/overall chart dynamics the stock is behaving similar to the prior runs IMO. However, ever since EXPR "squeezed" this past January its OBV has been very high comparatively to past runs. This is contibuting to the price and trend strength IMO as traders appear to be holding through the dips.
Note: Time cycles are inherently variable as changing economic and market dynamics, black swans, new regulations, etc. can greatly effect these cycles as related to equities.
Not financial advice.
From this count, on average the last 4 prior runs going back to 2011 lasted 435.75 days. The shortest run was 378 days.
Current run is 287 days. Thus current run is predicted to end by sometime in the 4th quarter 2021. See chart.
I also looked at the average price increase for the last four runs - which was ~1101 bars. Currently equates to a price of $11.67.
In terms of other indicators/overall chart dynamics the stock is behaving similar to the prior runs IMO. However, ever since EXPR "squeezed" this past January its OBV has been very high comparatively to past runs. This is contibuting to the price and trend strength IMO as traders appear to be holding through the dips.
Note: Time cycles are inherently variable as changing economic and market dynamics, black swans, new regulations, etc. can greatly effect these cycles as related to equities.
Not financial advice.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.